 | • レポートコード：MRC2209A021 • 出版社/出版日：Persistence Market Research / 2022年5月 • レポート形態：英文、PDF、276ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の本調査レポートでは、世界の硝子体内（IVT）注射剤市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主な包括・エクスクルージョン、市場機会分析、市場動向、疫学分析、診療報酬ガイドライン、パイプライン分析、世界経済の展望、薬効別（抗VEGF薬、副腎皮質ホルモン薬、抗生物質、抗ウイルス薬、抗真菌薬）分析、疾患別（糖尿病網膜症、黄斑変性症、眼内膜炎、網膜静脈閉塞症、その他）分析、流通チャネル別（病院薬局、小売薬局、ドラッグストア、通販薬局、その他）分析、地域別分析（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。なお、主要企業として、F. Hoffmann-La Roche Ltd、Regeneron Pharmaceuticals, Inc.、Bausch & Lomb、Novartis AG、Allergan、Alimera Sciences、ThromboGenics, Inc.、Bristol-Myers Squibb Companyなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・主な包括・エクスクルージョン ・市場機会分析 ・市場動向 ・疫学分析 ・診療報酬ガイドライン ・パイプライン分析 ・世界経済の展望 ・世界の硝子体内（IVT）注射剤市場規模：薬効別 - 抗VEGF薬における市場規模 - 副腎皮質ホルモン薬における市場規模 - 抗生物質における市場規模 - 抗ウイルス薬における市場規模 - 抗真菌薬における市場規模 ・世界の硝子体内（IVT）注射剤市場規模：疾患別 - 糖尿病網膜症における市場規模 - 黄斑変性症における市場規模 - 眼内膜炎における市場規模 - 網膜静脈閉塞症における市場規模 - その他疾患の市場規模 ・世界の硝子体内（IVT）注射剤市場規模：流通チャネル別 - 病院薬局での市場規模 - 小売薬局での市場規模 - ドラッグストアにおける市場規模 - 通販薬局における市場規模 - その他流通チャネルの市場規模 ・世界の硝子体内（IVT）注射剤市場規模：地域別 - 北米の硝子体内（IVT）注射剤市場規模 - 中南米の硝子体内（IVT）注射剤市場規模 - ヨーロッパの硝子体内（IVT）注射剤市場規模 - アジア太平洋の硝子体内（IVT）注射剤市場規模 - 中東/アフリカの硝子体内（IVT）注射剤市場規模 ・予測要因：関連性と影響 ・仮定 ・競争分析 ・調査手法 |
Intravitreal (IVT) Injectable Market Analysis 2022-2028
A recent market study published by Persistence Market Research (PMR) on the Intravitreal (IVT) Injectable Market including global industry analysis for 2013-2021 & opportunity assessment for 2022-2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Intravitreal (IVT) Injectable Market: Segmentation
The global Intravitreal (IVT) Injectable Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Indication
Macular Degeneration
Diabetic Retinopathy
Retinal Vein Occlusion
Endophthalmitis
Others
Drug Class
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Distributional Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail-order Pharmacies
Other
Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the Intravitreal (IVT) Injectable Market, which includes a snapshot of key findings and statistics. It also includes market size and revenue distribution of market segments of the market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation of the Intravitreal (IVT) Injectable Market in this chapter, which will help them understand the basics of the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the Intravitreal (IVT) Injectable Market over the forecast period. It also helps reader to understand both – supply side and demand side trends of the market.
Chapter 04 – Key Success Factors
This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. It also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the market, which include the drivers, restraints, and opportunities.
Chapter 05 – Intravitreal (IVT) Injectable Market Demand (Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
This section highlights the global market pricing analysis. It helps readers to understand the pricing variation of the market in various geographies.
Chapter 06 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis along with current COVID-19 impact that are expected to influence growth of the Intravitreal (IVT) Injectable Market over the forecast period. Moreover, in-depth information about the market dynamics and their impact on the market have been provided in the successive section.
Chapter 07 – Global Manual Resuscitator Market Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
This section explains the global market value analysis and forecast for the Intravitreal (IVT) Injectable during the forecast period based on Drug Class. It includes a detailed analysis of the historical Intravitreal (IVT) Injectable Market, along with an opportunity analysis of the future. Based on Drug Class, the Intravitreal (IVT) Injectable market is segmented into Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals.
Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2028).
Chapter 08 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Indication
Based on Indication, the Intravitreal (IVT) Injectable market is segmented into Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others. In this chapter, readers can find information about the key trends and developments in Intravitreal (IVT) Injectable and market attractiveness analysis based on Indication.
Chapter 09 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Region
This chapter explains how the market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).
Chapter 10 – North America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter includes a detailed analysis of growth of North America’s Intravitreal (IVT) Injectable Market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.
Chapter 11 – Latin America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Chapter 12 –Europe Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.
Chapter 13 – South Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the Intravitreal (IVT) Injectable Market in India, Thailand, Indonesia, Malaysia and rest of South Asia.
Chapter 14 – East Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the market in East Asia by focusing on China, Japan & South Korea. This section also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in East Asia.
Chapter 15 – Oceania Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the Intravitreal (IVT) Injectable Market in Oceania. It also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in Australia and New Zealand.
Chapter 16 – MEA Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides information about how the Intravitreal (IVT) Injectable Market will grow in GCC Countries, South Africa, Turkey and the Rest of MEA during the forecast period.
Chapter 17 – Key and Emerging Countries Intravitreal (IVT) Injectable Market Analysis 2013-2021 and Forecast 2022-2028
This section delves deep into Intravitreal (IVT) Injectable Market for key and emerging countries. Readers can understand the market value and volume by product type, modality,and end user for key countries.
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key players operating in Intravitreal (IVT) Injectable Market.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Intravitreal (IVT) Injectable Market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., and Bristol-Myers Squibb Company.
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the Intravitreal (IVT) Injectable report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Intravitreal (IVT) Injectable Market.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Key Inclusions and Exclusions
4. Market Opportunity Analysis
4.1. Macro-Economic Factors
4.2. Opportunity Analysis
5. Market Dynamics
5.1. Drivers
5.1.1. Supply Side Drivers
5.1.2. Demand Side Drivers
5.2. Restraints
5.3. Trends
6. Epidemiology Analysis
7. Reimbursement Guidelines
8. Pipeline Analysis
9. Global Economic Outlook
9.1. Gross Domestic Indication Type by Region & Country, 2006 – 2021
9.2. Global Healthcare Market Indicators
10. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Drug Class
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Drug Class, 2013–2021
10.2.1. Anti-VEGF
10.2.2. Corticosteroids
10.2.3. Antibiotics
10.2.4. Antivirals
10.2.5. Antifungals
10.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
10.4. Market Attractiveness Analysis By Drug Class
11. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Indication, 2013–2021
11.2.1. Diabetic Retinopathy
11.2.2. Macular Degeneration
11.2.3. Endophthalmitis
11.2.4. Retinal Vein Occlusions
11.2.5. Others
11.3. Market Size (US$ Mn) Forecast By Indication, 2022–2028
11.4. Market Attractiveness Analysis By Indication
12. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Distributional Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) By Distributional Channel, 2013–2021
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.2.3. Drug Stores
12.2.4. Mail Order Pharmacies
12.2.5. Others
12.3. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
12.4. Market Attractiveness Analysis By Distributional Channel
13. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) By Region, 2013–2021
13.2.1. North America
13.2.2. Latin America
13.2.3. Europe
13.2.4. South Asia
13.2.5. East Asia
13.2.6. Oceania
13.2.7. Middle East and Africa
13.2.8. Emerging Countries
13.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
13.4. Market Attractiveness Analysis By Region
14. North America Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and By Country, 2013 – 2017
14.2.1. U.S.
14.2.2. Canada
14.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
14.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
14.4.1. Anti-VEGF
14.4.2. Corticosteriods
14.4.3. Antibiotics
14.4.4. Antivirals
14.4.5. Antifungals
14.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
14.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
14.6.1. Diabetic Retinopathy
14.6.2. Macular Degeneration
14.6.3. Endophthalmitis
14.6.4. Retinal Vein Occlusion
14.6.5. Others
14.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
14.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
14.8.1. Hospital Pharmacies
14.8.2. Retail Pharmacies
14.8.3. Drug Stores
14.8.4. Mail Order Pharmacies
14.8.5. Others
14.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Drug Class
14.10.3. By Indication
14.10.4. By Distributional Channel
14.11. Drivers and Restraints: Impact Analysis
15. Latin America Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
15.2.1. Brazil
15.2.2. Mexico
15.2.3. Rest of Latin America
15.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
15.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
15.4.1. Anti-VEGF
15.4.2. Corticosteriods
15.4.3. Antibiotics
15.4.4. Antivirals
15.4.5. Antifungals
15.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
15.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
15.6.1. Diabetic Retinopathy
15.6.2. Macular Degeneration
15.6.3. Endophthalmitis
15.6.4. Retinal Vein Occlusion
15.6.5. Others
15.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
15.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
15.8.1. Hospital Pharmacies
15.8.2. Retail Pharmacies
15.8.3. Drug Stores
15.8.4. Mail Order Pharmacies
15.8.5. Others
15.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
15.10. Market Attractiveness Analysis
15.10.1. By Country
15.10.2. By Drug Class
15.10.3. By Indication
15.10.4. By Distributional Channel
15.11. Drivers and Restraints: Impact Analysis
16. Europe Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
16.2.1. Germany
16.2.2. Italy
16.2.3. France
16.2.4. U.K.
16.2.5. Spain
16.2.6. BENELUX
16.2.7. Russia
16.2.8. Rest of Europe
16.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
16.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
16.4.1. Anti-VEGF
16.4.2. Corticosteriods
16.4.3. Antibiotics
16.4.4. Antivirals
16.4.5. Antifungals
16.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
16.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
16.6.1. Diabetic Retinopathy
16.6.2. Macular Degeneration
16.6.3. Endophthalmitis
16.6.4. Retinal Vein Occlusion
16.6.5. Others
16.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
16.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
16.8.1. Hospital Pharmacies
16.8.2. Retail Pharmacies
16.8.3. Drug Stores
16.8.4. Mail Order Pharmacies
16.8.5. Others
16.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
16.10. Market Attractiveness Analysis
16.10.1. By Country
16.10.2. By Drug Class
16.10.3. By Indication
16.10.4. By Distributional Channel
16.11. Drivers and Restraints: Impact Analysis
17. South Asia Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
17.2.1. India
17.2.2. Thailand
17.2.3. Indonesia
17.2.4. Malaysia
17.2.5. Rest of South Asia
17.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
17.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
17.4.1. Anti-VEGF
17.4.2. Corticosteriods
17.4.3. Antibiotics
17.4.4. Antivirals
17.4.5. Antifungals
17.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
17.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
17.6.1. Diabetic Retinopathy
17.6.2. Macular Degeneration
17.6.3. Endophthalmitis
17.6.4. Retinal Vein Occlusion
17.6.5. Others
17.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
17.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
17.8.1. Hospital Pharmacies
17.8.2. Retail Pharmacies
17.8.3. Drug Stores
17.8.4. Mail Order Pharmacies
17.8.5. Others
17.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
17.10. Market Attractiveness Analysis
17.10.1. By Country
17.10.2. By Drug Class
17.10.3. By Indication
17.10.4. By Distributional Channel
17.11. Drivers and Restraints: Impact Analysis
18. East Asia Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
18.2.1. China
18.2.2. Japan
18.2.3. South Korea
18.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
18.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
18.4.1. Anti-VEGF
18.4.2. Corticosteriods
18.4.3. Antibiotics
18.4.4. Antivirals
18.4.5. Antifungals
18.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
18.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
18.6.1. Diabetic Retinopathy
18.6.2. Macular Degeneration
18.6.3. Endophthalmitis
18.6.4. Retinal Vein Occlusion
18.6.5. Others
18.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
18.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
18.8.1. Hospital Pharmacies
18.8.2. Retail Pharmacies
18.8.3. Drug Stores
18.8.4. Mail Order Pharmacies
18.8.5. Others
18.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
18.10. Market Attractiveness Analysis
18.10.1. By Country
18.10.2. By Drug Class
18.10.3. By Indication
18.10.4. By Distributional Channel
18.11. Drivers and Restraints: Impact Analysis
19. Oceania Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
19.2.1. Australia
19.2.2. New Zealand
19.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
19.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
19.4.1. Anti-VEGF
19.4.2. Corticosteriods
19.4.3. Antibiotics
19.4.4. Antivirals
19.4.5. Antifungals
19.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
19.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
19.6.1. Diabetic Retinopathy
19.6.2. Macular Degeneration
19.6.3. Endophthalmitis
19.6.4. Retinal Vein Occlusion
19.6.5. Others
19.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
19.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
19.8.1. Hospital Pharmacies
19.8.2. Retail Pharmacies
19.8.3. Drug Stores
19.8.4. Mail Order Pharmacies
19.8.5. Others
19.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
19.10. Market Attractiveness Analysis
19.10.1. By Country
19.10.2. By Drug Class
19.10.3. By Indication
19.10.4. By Distributional Channel
19.11. Drivers and Restraints: Impact Analysis
20. Middle East and Africa Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
20.2.1. GCC Countries
20.2.2. Turkey
20.2.3. Northern Africa
20.2.4. South Africa
20.2.5. Rest of Middle East and Africa
20.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
20.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
20.4.1. Anti-VEGF
20.4.2. Corticosteriods
20.4.3. Antibiotics
20.4.4. Antivirals
20.4.5. Antifungals
20.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
20.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
20.6.1. Diabetic Retinopathy
20.6.2. Macular Degeneration
20.6.3. Endophthalmitis
20.6.4. Retinal Vein Occlusion
20.6.5. Others
20.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
20.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
20.8.1. Hospital Pharmacies
20.8.2. Retail Pharmacies
20.8.3. Drug Stores
20.8.4. Mail Order Pharmacies
20.8.5. Others
20.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
20.10. Market Attractiveness Analysis
20.10.1. By Country
20.10.2. By Drug Class
20.10.3. By Indication
20.10.4. By Distributional Channel
20.11. Drivers and Restraints: Impact Analysis
21. Emerging Countries Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
21.1. Introduction
21.2. Global Vs. Country Growth Comparison
22. China Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
22.1. Introduction
22.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
22.2.1. Anti-VEGF
22.2.2. Corticosteriods
22.2.3. Antibiotics
22.2.4. Antivirals
22.2.5. Antifungals
22.2.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
22.3. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
22.3.1. Diabetic Retinopathy
22.3.2. Macular Degeneration
22.3.3. Endophthalmitis
22.3.4. Retinal Vein Occlusion
22.3.5. Others
22.4. Market Size (US$ Mn) Forecast By Indication, 2022–2028
22.5. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
22.5.1. Hospital Pharmacies
22.5.2. Retail Pharmacies
22.5.3. Drug Stores
22.5.4. Mail Order Pharmacies
22.5.5. Others
22.6. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
22.7. Market Attractiveness Analysis
22.7.1. By Country
22.7.2. By Drug Class
22.7.3. By Indication
22.7.4. By Distributional Channel
22.8. PESTLE Analysis
22.9. Drivers and Restraints: Impact Analysis
23. India Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
23.1. Introduction
23.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
23.2.1. Anti-VEGF
23.2.2. Corticosteriods
23.2.3. Antibiotics
23.2.4. Antivirals
23.2.5. Antifungals
23.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
23.4. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
23.4.1. Diabetic Retinopathy
23.4.2. Macular Degeneration
23.4.3. Endophthalmitis
23.4.4. Retinal Vein Occlusion
23.4.5. 23.3.5. Others
23.5. Market Size (US$ Mn) Forecast By Indication, 2022–2028
23.6. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
23.6.1. 23.5.1. Hospital Pharmacies
23.6.2. 23.5.2. Retail Pharmacies
23.6.3. 23.5.3. Drug Stores
23.6.4. 23.5.4. Mail Order Pharmacies
23.6.5. 23.5.5. Others
23.7. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
23.8. Market Attractiveness Analysis
23.8.1. 23.7.1. By Country
23.8.2. 23.7.2. By Drug Class
23.8.3. 23.7.3. By Indication
23.8.4. 23.7.4. By Distributional Channel
23.9. PESTLE Analysis
23.10. Drivers and Restraints: Impact Analysis
24. Mexico Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
24.1. Introduction
24.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
24.2.1. Anti-VEGF
24.2.2. Corticosteriods
24.2.3. Antibiotics
24.2.4. Antivirals
24.2.5. Antifungals
24.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
24.4. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
24.4.1. 24.3.1. Diabetic Retinopathy
24.4.2. 24.3.2. Macular Degeneration
24.4.3. 24.3.3. Endophthalmitis
24.4.4. 24.3.4. Retinal Vein Occlusion
24.4.5. 24.3.5. Others
24.5. Market Size (US$ Mn) Forecast By Indication, 2022–2028
24.6. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
24.6.1. 24.5.1. Hospital Pharmacies
24.6.2. 24.5.2. Retail Pharmacies
24.6.3. 24.5.3. Drug Stores
24.6.4. 24.5.4. Mail Order Pharmacies
24.6.5. 24.5.5. Others
24.7. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
24.8. Market Attractiveness Analysis
24.8.1. 24.7.1. By Country
24.8.2. 24.7.2. By Drug Class
24.8.3. 24.7.3. By Indication
24.8.4. 24.7.4. By Distributional Channel
24.9. PESTLE Analysis
24.10. Drivers and Restraints: Impact Analysis
25. Forecast Factors: Relevance and Impact
26. Forecast Assumptions
27. Competition Analysis
27.1. Competition Dashboard
27.2. Competition Deep Dive
27.2.1. F. Hoffmann-La Roche Ltd
27.2.1.1. Overview
27.2.1.2. Key Financials
27.2.1.3. SWOT Analysis
27.2.1.4. Key Developments
27.2.1.5. Key Strategy
27.2.2. Regeneron Pharmaceuticals, Inc.
27.2.2.1. Overview
27.2.2.2. Key Financials
27.2.2.3. SWOT Analysis
27.2.2.4. Key Developments
27.2.2.5. Key Strategy
27.2.3. Bausch & Lomb
27.2.3.1. Overview
27.2.3.2. Key Financials
27.2.3.3. SWOT Analysis
27.2.3.4. Key Developments
27.2.3.5. Key Strategy
27.2.4. Novartis AG
27.2.4.1. Overview
27.2.4.2. Key Financials
27.2.4.3. SWOT Analysis
27.2.4.4. Key Developments
27.2.4.5. Key Strategy
27.2.5. Allergan
27.2.5.1. Overview
27.2.5.2. Key Financials
27.2.5.3. SWOT Analysis
27.2.5.4. Key Developments
27.2.5.5. Key Strategy
27.2.6. Alimera Sciences
27.2.6.1. Overview
27.2.6.2. Key Financials
27.2.6.3. SWOT Analysis
27.2.6.4. Key Developments
27.2.6.5. Key Strategy
27.2.7. ThromboGenics, Inc.
27.2.7.1. Overview
27.2.7.2. Key Financials
27.2.7.3. SWOT Analysis
27.2.7.4. Key Developments
27.2.7.5. Key Strategy
27.2.8. Bristol-Myers Squibb Company
27.2.8.1. Overview
27.2.8.2. Key Financials
27.2.8.3. SWOT Analysis
27.2.8.4. Key Developments
27.2.8.5. Key Strategy
28. Assumptions and Acronyms Used
29. Research Methodology
Table 1: Expenditure on Health, (% of GDP), by Country, 2013–2021Table 2: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 3: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 4: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 5: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Region
Table 6: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 7: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 8: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 9: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 10: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 11: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 12: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 13: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 14: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 15: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 16: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 17: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 18: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 19: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 20: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 21: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 22: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 23: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 24: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 25: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 26: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 27: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 28: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 29: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 30: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
Table 31: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 32: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 33: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 34: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 35: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 36: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel36
Table 37: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 38: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 39: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel
Table 40: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Drug Class
Table 41: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
Table 42: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Distributional Channel